Post-marketing Clinical Study of Irbesartan <Evaluation of safety and efficacy of long-term administration>
Latest Information Update: 27 May 2016
At a glance
- Drugs Irbesartan (Primary)
- Indications Hypertension
- Focus Adverse reactions
- Sponsors Sumitomo Dainippon Pharma
- 27 May 2016 New trial record